
    
      The purpose of this study is to assess the Overall Response Rate (ORR) = Complete Response
      (CR) + Partial Response (PR) in adult Diffuse Large B Cell Lymphoma (DLBCL) patients
      progressing or relapsed after prior R-CHOP treatment not suitable for ASCT treated with
      O-IVAC salvage chemotherapy regimen. The secondary objective is the evaluation of
      progression-free survival (PFS), event-free survival (EFS), overall survival (OS), safety and
      tolerability.
    
  